Cardlytics (CDLX) PT Lowered to $120 at Needham & Company on Slower Than Expected Recovery
Tweet Send to a Friend
Needham & Company analyst Kyle Peterson lowered the price target on Cardlytics (NASDAQ: CDLX) to $120.00 (from $135.00) after 2Q ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
